One last thing Maybe the anticipated relationship with Jansen will ensure PIQ gets the green light and stamp of FDA approval. The relationship with Jansen is probably our best insurance against any kind of unscrupulous dealings with the Federal Agency. Jansen really need Promarker D on board to justify future sales of their expensive new drug Canafloxin which slows kidney dysfunction in at risk diabetics. Phase 2 results are critical to this and it looks like the new hearing and results release will closely coincide with June 30. l think this is will get us across the line simple because big American Pharma has no limit of lobbying power stateside.
Cheers.
One last thing Maybe the anticipated relationship with Jansen...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
89.0¢ |
Change
0.020(2.30%) |
Mkt cap ! $116.4M | |||
| Open | High | Low | Value | Volume |
| 88.0¢ | 89.0¢ | 87.5¢ | $64.67K | 73.36K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 31818 | 88.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 89.0¢ | 12198 | 1 |
View Market Depth
| Last trade - 10.11am 08/07/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |